Aim: Oxidative stress caused by untargeted anticancer drugs in tissues causes serious side effects such as cardiotoxicity, neurotoxicity, and hepatotoxicity. Paclitaxel is one of the taxane-derived chemotherapeutic drugs used in the treatment of solid tumors. Such chemotherapeutics are known to cause nerve damage. Epigallocatechin gallate (EGCG), which is the most active component of catechins in tea, is an important antioxidant and has an important role in ensuring DNA stability and healthy life. In this study, possible protective effects of epigallocatechin gallate against paclitaxel-induced oxidative stress were investigated. Method: 32 rats forming our study groups; divided into 4 groups with 8 rats in each group. As a result of the experimental protocol, the animals were sacrificed and sciatic nerve tissue was isolated. After nervous tissue homogenization, superoxide dismutase (SOD), catalase (KAT) enzyme activities and glutathione (GSH), malondialdehyde (MDA) and nitric oxide (NO) levels were examined. Results: According to the data obtained, paclitaxel administration decreased SOD, CAT activity and GSH levels and increased MDA levels, however, EGCG treatment increased SOD, CAT activity and GSH levels and decreased MDA levels. Conclusion: As a result of our study, it was shown that EGCG can prevent the oxidative stress caused by paclitaxel in sciatic nerve tissue.
Amaç: Hedeflenmemiş antikanser ilaçlardan kaynaklı oksidatif stres çeşitli dokularda kardiyotoksisite, nörotoksisite ve hepatotoksisite gibi önemli yan etkilere neden olmaktadır. Paklitaksel, solid tümörlerin tedavisinde kullanılan taksan türevi kemoterapötik ilaçlardan biridir. Bu tür kemoterapötiklerin sinir hasarı oluşturduğu bilinmektedir. Çaydabulunan kateşinlerin en aktif bileşeni olan epigallokateşin gallat (EGCG) önemli bir antioksidan olup, DNA stabilitesinin sağlanılması ve sağlıklı yaşamda önemli bir role sahiptir. Çalışmamızda, paklitaksel ile oluşturulmuş oksidatif strese karşı epigallokateşin gallatın olası koruyucu etkileri incelenmiştir. Yöntem: Çalışma gruplarımızı oluşturan 32 sıçan; her grupta 8 sıçan olacak şekilde 4 gruba ayrılmıştır. Deney protokolünün sonunda sıçanlar sakrifiye edilerek siyatik sinir dokusu izole edilmiştir. Sinir dokusu homojenize edildikten sonra süperoksitdismutaz (SOD), katalaz (KAT) enzim aktiviteleri ileglutatyon (GSH), malondialdehid (MDA) ve nitrik oksit (NO) seviyeleri incelenmiştir. Bulgular: Elde edilen verilere göre paklitaksel uygulamasının SOD, KAT aktivitesi ve GSH düzeylerini azalttığı MDA seviyesini artırdığı, bununla birlikte EGCG tedavisinin SOD, KAT aktivitesi ve GSH düzeylerini arttırdığı ve MDA seviyesini azalttığı bulunmuştur. Sonuç: Çalışmamızın sonucunda EGCG’in paklitakselin siyatik sinir dokusunda neden olduğu oksidatif stresi engelleyebileceği gösterilmiştir.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Publication Date | April 30, 2020 |
Submission Date | January 27, 2020 |
Acceptance Date | March 13, 2020 |
Published in Issue | Year 2020 Volume: 13 Issue: 1 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.